Literature DB >> 17384519

Loss of taste-induced hypertension--caveat for taste modulation as a therapeutic option in obesity.

L Czupryniak1, J Loba.   

Abstract

OBJECTIVE: Effective treatment of obesity is extremely difficult, and taste modulation has been suggested as a feasible option. We aim at presenting dangers associated with stroke-induced taste impairment.
METHODS: A case report is presented with clinical and laboratory findings. We review literature on the effect of taste modulation on body weight.
RESULTS: Eight months after suffering stroke, a 63-year old obese woman with a nine year-old history of type 2 diabetes reported headache and poor general feeling. Physical examination revealed significantly elevated blood pressure of 190/110 mmHg. The patient had never had elevated blood pressure before nor ever been taking any antihypertensive medication. However, stroke resulted in severe persisting dysgeusia. We found out that she had been using up to 110 g of salt daily to make her meals palatable. Standard gustatory tests confirmed severe taste impairment, reflecting the lesion of the glossopharyngeal nerve. Taste loss was not associated with body weight reduction. Limiting daily salt intake to 5 g within 4 weeks resulted in lowering blood pressure to 120/70 mmHg.
CONCLUSION: Stroke-induced dysgeusia may lead to increased salt intake in a type 2 diabetes patient, which caused development of severe hypertension. The taste loss did not yield any weight reduction. We suggest that aiming at reducing body weight by means of taste modulation should be done with caution. Physicians must be aware that patients may try to overcome dysgeusia by additional salt intake, if not adequately informed of the risk thereof.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17384519     DOI: 10.1007/bf03327775

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN: 1124-4909            Impact factor:   4.652


  19 in total

1.  Smell, taste, head trauma, and hypopituitarism.

Authors:  R I Henkin
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

2.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

3.  Altered food preference after cortical infarction: Korean style.

Authors:  Jong S Kim; Smi Choi
Journal:  Cerebrovasc Dis       Date:  2002       Impact factor: 2.762

4.  Disorders of smell, taste, and food intake in a patient with a dorsomedial thalamic infarct.

Authors:  M Rousseaux; P Muller; I Gahide; Y Mottin; M Romon
Journal:  Stroke       Date:  1996-12       Impact factor: 7.914

5.  Disordered gustatory acuity in liver disease.

Authors:  F R Smith; R I Henkin; R B Dell
Journal:  Gastroenterology       Date:  1976-04       Impact factor: 22.682

6.  Alterations in taste thresholds in men with chronic obstructive pulmonary disease.

Authors:  K Chapman-Novakofski; M S Brewer; J Riskowski; C Burkowski; L Winter
Journal:  J Am Diet Assoc       Date:  1999-12

Review 7.  Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction.

Authors:  R I Henkin
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

Review 8.  Stroke.

Authors:  Charles Warlow; Cathie Sudlow; Martin Dennis; Joanna Wardlaw; Peter Sandercock
Journal:  Lancet       Date:  2003-10-11       Impact factor: 79.321

Review 9.  Long-term pharmacotherapy for obesity and overweight.

Authors:  R Padwal; S K Li; D C W Lau
Journal:  Cochrane Database Syst Rev       Date:  2003

10.  Gustatory disturbance due to cerebrovascular disorder.

Authors:  K Onoda; M Ikeda
Journal:  Laryngoscope       Date:  1999-01       Impact factor: 3.325

View more
  1 in total

Review 1.  Altered taste and stroke: a case report and literature review.

Authors:  Tara M Dutta; Anne F Josiah; Carolyn A Cronin; George F Wittenberg; John W Cole
Journal:  Top Stroke Rehabil       Date:  2013 Jan-Feb       Impact factor: 2.119

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.